Back to top

Image: Bigstock

Top Ranked Value Stocks to Buy for April 6th

Read MoreHide Full Article

Here are four stocks with buy rank and strong value characteristics for investors to consider today, April 6th:

Century Communities, Inc. (CCS - Free Report) : This designer of single-family attached and detached homes has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 10.3% over the last 60 days.

Century Communities has a price-to-earnings ratio (P/E) of 2.50, compared with 4.80 for the industry. The company possesses a Value Score of A.

Daqo New Energy Corp. (DQ - Free Report) : This manufacturer and marketer of polysilicon to photovoltaic product manufacturers has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 8.4% over the last 60 days.

Daqo New Energy has a price-to-earnings ratio (P/E) of 5.86, compared with 10.80 for the industry. The company possesses a Value Score of A.

Fluor Corporation (FLR - Free Report) : This provider of engineering, procurement, construction, fabrication and modularization, operation, maintenance and asset integrity and project management services has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 2% over the last 60 days.

Fluor has a price-to-earnings ratio (P/E) of 3.94, compared with 5.10 for the industry. The company possesses a Value Score of A.

Hilltop Holdings Inc. (HTH - Free Report) : This provider of banking and financial products and services has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 11.4% over the last 60 days.

Hilltop has a price-to-earnings ratio (P/E) of 6.55, compared with 8.40 for the industry. The company possesses a Value Score of A.

See the full list of top ranked stocks here.

Learn more about the Value score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>